Stem cell therapy in pulmonary hypertension: current practice and future opportunities

Pulmonary hypertension (PH) is a progressive disease characterised by elevated pulmonary arterial pressure and right-sided heart failure. While conventional drug therapies, including prostacyclin analogues, endothelin receptor antagonists and phosphodiesterase type 5 inhibitors, have been shown to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Ruixuan, Xu, Tingting, Wang, Xinghong, Yang, Lehe, Wang, Jian, Huang, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523152/
https://www.ncbi.nlm.nih.gov/pubmed/37758272
http://dx.doi.org/10.1183/16000617.0112-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523152/
https://www.ncbi.nlm.nih.gov/pubmed/37758272
http://dx.doi.org/10.1183/16000617.0112-2023

Ejemplares similares